Workflow
构建平台化生态
icon
Search documents
麦迪科技(603990.SH):预计2025年归母净利润为3900万元至4400万元
Ge Long Hui A P P· 2026-01-29 09:56
Core Viewpoint - The company, MediTech (603990.SH), expects a net profit attributable to shareholders of the parent company to be between 39 million and 44 million yuan for 2025, with a net profit excluding non-recurring gains and losses projected to be between 10 million and 15 million yuan [1] Group 1 - The main reason for the turnaround to profitability is the impact of the photovoltaic business, which resulted in a negative net profit for 2024 [1] - In 2025, the company plans to complete a significant asset sale to divest from the photovoltaic business [1] - The company is focusing on three strategic initiatives: concentrating on the medical core business, enhancing asset-light attributes, and building a platform-based ecosystem to optimize its business structure and improve operational stability [1] Group 2 - The company aims to enhance its profitability through refined management practices, continuously improving operational efficiency and cost control [1]
苏州麦迪斯顿医疗科技股份有限公司2025年半年度业绩预告
Core Viewpoint - The company, Suzhou Mediston Medical Technology Co., Ltd., is expected to achieve a turnaround in its financial performance for the first half of 2025, projecting a net profit of between 25 million to 27 million yuan, compared to a significant loss in the same period of the previous year [2][3]. Financial Performance Summary - The projected net profit for the first half of 2025 is estimated to be between 25 million to 27 million yuan, with a net profit excluding non-recurring gains and losses expected to be between 4 million to 6 million yuan [2][4]. - In the same period of 2024, the company reported a net loss of 76.3352 million yuan, indicating a substantial improvement in financial performance [3][6]. Reasons for Turnaround - The primary reason for the expected turnaround is the completion of a significant asset sale that involved divesting from the loss-making photovoltaic business, which had negatively impacted the company's profitability in the previous year [9]. - The company has adopted a strategic focus on its core medical business, enhancing its asset-light model, and building a platform-based ecosystem, which has contributed to improved operational efficiency and cost control [9].